(Q37533754)

20 August 2017

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. (English)

1 reference

20 August 2017

1 reference

S W Young

1

1 reference

20 August 2017

F Qing

2

1 reference

20 August 2017

A Harriman

3

1 reference

20 August 2017

J L Sessler

4

1 reference

20 August 2017

W C Dow

5

1 reference

20 August 2017

T D Mody

6

1 reference

20 August 2017

G W Hemmi

7

1 reference

20 August 2017

Y Hao

8

1 reference

20 August 2017

R A Miller

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

Proceedings of the National Academy of Sciences of the United States of America

20 August 2017

1 reference

20 August 2017

93

1 reference

20 August 2017

6610-6615

1 reference

20 August 2017

13

1 reference

describes a project that uses

20 August 2017

magnetic resonance imaging

1 reference

DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect

inferred from title

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

A phase i study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Failla Memorial Lecture. Redox, radiation, and reductive bioactivation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Comparisons of cellular radiation response using absolute rather than relative parameters

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Radiotherapy for primary and secondary brain tumors.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Determinants of radiosensitivity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Oxygen diffusion and the distribution of cellular radiosensitivity in tumours

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

The Phenomenon of Reoxygenation and Its Implications for Fractionated Radiotherapy

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Linear-Quadratic Analysis of Radiosensitization by Halogenated Pyrimidines: I. Radiosensitization of Human Colon Cancer Cells by Iododeoxyuridine

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39073

A phase I study of the hypoxic cell radiosensitizer Ro-03-8799

25 June 2018

1 reference

12 December 2020

The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations

1 reference

12 December 2020

A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799

1 reference

12 December 2020

Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile

1 reference

12 December 2020

Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs

1 reference

12 December 2020

The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)

1 reference

12 December 2020

Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosome damage and its correlation with cell killing

1 reference

12 December 2020

Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation

1 reference

12 December 2020

SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes

1 reference

12 December 2020

Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging

1 reference

12 December 2020

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.93.13.6610

1 reference

20 August 2017

0 references

1 reference

20 August 2017

1 reference